DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30/6/2004
Amended Announcements
Please refer to the earlier announcement reference number: CS-040820-67070
| DUOPHARMA BIOTECH BHD |
|
Quarterly report for the financial period ended | 30/06/2004 |
| Quarter | 2 |
| Financial Year End | 31/12/2004 |
| The figures | have not been audited |
| Remarks : |
| Amendment to Dividend per share (Item 6 below) is made to reflect the appropriate interim dividend amount approved by the Board of Directors as per Note B12 to Interim Financial Report |
SUMMARY OF KEY FINANCIAL INFORMATION30/06/2004 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/06/2004 | 30/06/2003 | 30/06/2004 | 30/06/2003 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 20,127 | 20,269 | 39,502 | 39,782 |
| 2 | Profit/(loss) before tax | 6,987 | 6,057 | 14,075 | 12,092 |
| 3 | Profit/(loss) after tax and minority interest | 5,924 | 4,541 | 11,549 | 8,917 |
| 4 | Net profit/(loss) for the period | 5,924 | 4,541 | 11,549 | 8,917 |
| 5 | Basic earnings/(loss) per share (sen) | 9.87 | 7.57 | 19.25 | 14.86 |
| 6 | Dividend per share (sen) | 3.00 | 5.00 | 3.00 | 5.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.5800 | 1.4500 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
| Company Name | DUOPHARMA BIOTECH BHD |
| Stock Name | DBIOTEC |
| Date Announced | 30 Aug 2004 |
| Category | Financial Results |
| Reference No | CS-040803-41407 |